HSF4 and epidermolysis bullosa: To provide further evidence that TG2 affects the pathogenesis of EB, we treated EB mice by using an intraperitoneal injection of CTM once per day for 7d during OVA sensitization and during OVA challenge respectively (Fig. 6a).